Atherosclerosis
Conditions
Interventions
Coronary Heart Disease Multi-omics Classification 1:None
Coronary Heart Disease Multi-omics Classification 2:None
Coronary Heart Disease Multi-omics Classification 3:None
Coronary Heart Disease Multi-omics Classification 4:None
Sponsors
Shanghai Tenth People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients with a definitive diagnosis of stable or unstable coronary artery disease (CAD) who have been clinically evaluated as requiring coronary endarterectomy (CE) (2) Aged >18 years (3) Capable of comprehending the study objectives, voluntarily agreeing to participate, and having signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Diffuse coronary small vessel disease; Extensively calcified and non-operable coronary arteries; End-stage coronary artery disease with no revascularization value; Active phase of acute myocardial infarction; Severe left ventricular dysfunction (ejection fraction 80 years old) with multiple systemic comorbidities; (3) Severe hepatic or renal insufficiency; (4) Coagulation disorders or bleeding diathesis; (5) History of stroke within the past 6 months; (6) Patients with limited life expectancy (<1 year); (7) History of multiple coronary interventions leading to vascular structural changes; (8) Severe chronic pulmonary disease; (9) Participants who have participated in or are currently participating in any other clinical trial involving devices or medications within the past 3 months; (10) Other circumstances deemed by the investigator as unsuitable for clinical trial participation. This translation maintains medical terminology accuracy while ensuring clarity and readability for clinical research contexts.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cardiovascular and cerebrovascular events; | — |
Countries
China
Contacts
Public ContactWenliang Che
The Tenth People's Hospital affiliated to Tongji University
Outcome results
None listed